Treasurer of the State of North Carolina’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.08M Buy
67,701
+1,439
+2% +$114K 0.02% 608
2025
Q4
$5.24M Sell
66,262
-3,600
-5% -$271K 0.02% 602
2025
Q3
$4.57M Sell
69,862
-2,725
-4% -$133K 0.01% 660
2025
Q2
$2.87M Buy
72,587
+994
+1% +$32.5K 0.01% 819
2025
Q1
$2.16M Buy
71,593
+2,790
+4% +$91.4K 0.01% 844
2024
Q4
$2.4M Buy
68,803
+440
+0.6% +$16.4K 0.01% 839
2024
Q3
$2.74M Buy
68,363
+5,250
+8% +$244K 0.01% 806
2024
Q2
$3.01M Sell
63,113
-469
-0.7% -$19.2K 0.01% 745
2024
Q1
$2.76M Buy
63,582
+430
+0.7% +$20.5K 0.01% 779
2023
Q4
$3.19M Buy
63,152
+620
+1% +$29.7K 0.02% 712
2023
Q3
$2.84M Buy
62,532
+310
+0.5% +$12.8K 0.02% 720
2023
Q2
$2.55M Buy
62,222
+480
+0.8% +$18.4K 0.01% 772
2023
Q1
$2.21M Buy
61,742
+440
+0.7% +$16.5K 0.01% 787
2022
Q4
$2.31M Buy
61,302
+780
+1% +$32.8K 0.01% 759
2022
Q3
$2.68M Buy
60,522
+780
+1% +$32.9K 0.02% 678
2022
Q2
$2.21M Buy
59,742
+8,071
+16% +$304K 0.01% 766
2022
Q1
$1.91M Buy
51,671
+825
+2% +$27K 0.01% 818
2021
Q4
$1.55M Buy
50,846
+330
+0.7% +$10.4K 0.01% 895
2021
Q3
$1.69M Buy
50,516
+1,709
+4% +$64.4K 0.01% 876
2021
Q2
$1.95M Buy
48,807
+890
+2% +$34.9K 0.01% 837
2021
Q1
$2.15M Sell
47,917
-2,198
-4% -$123K 0.01% 766
2020
Q4
$2.83M Buy
50,115
+180
+0.4% +$8.97K 0.02% 645
2020
Q3
$2.37M Sell
49,935
-90
-0.2% -$5K 0.02% 639
2020
Q2
$2.95M Sell
50,025
-10,955
-18% -$609K 0.02% 546
2020
Q1
$2.88M Buy
60,980
+22,050
+57% +$1.23M 0.03% 509
2019
Q4
$2.35M Sell
38,930
-250
-0.6% -$14.9K 0.02% 541
2019
Q3
$2.35M Sell
39,180
-14,650
-27% -$955K 0.02% 515
2019
Q2
$3.46M Sell
53,830
-3,090
-5% -$218K 0.02% 591
2019
Q1
$4.62M Buy
56,920
+251
+0.4% +$16.2K 0.03% 484
2018
Q4
$3.06M Sell
56,669
-6,767
-11% -$345K 0.02% 567
2018
Q3
$3.27M Buy
63,436
+35,435
+127% +$1.66M 0.02% 608
2018
Q2
$1.17M Buy
28,001
+16,513
+144% +$732K 0.01% 821
2018
Q1
$506K Buy
+11,488
New +$584K 0.01% 835

Other funds holding IONS

Treasurer of the State of North Carolina's IONS Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Ionis Pharmaceuticals (IONS) stake by 2.2% in Q1 2026, buying an estimated $114K and bringing the position to 67,701 shares worth $5.08M. The position accounts for 0.02% of the portfolio, ranked #608.

Treasurer of the State of North Carolina first reported a position in IONS in Q1 2018 and has held it in 33 quarters since. The position peaked at $5.24M in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Treasurer of the State of North Carolina held 67,701 shares of Ionis Pharmaceuticals worth $5.08M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 1,439 Ionis Pharmaceuticals shares in Q1 2026, an estimated $114K.
  • Ionis Pharmaceuticals made up 0.02% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #608 holding.
  • Treasurer of the State of North Carolina first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
  • Treasurer of the State of North Carolina's Ionis Pharmaceuticals position peaked at $5.24M in Q4 2025.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.